Saturday 17 October 2026
Export MRM’s income statement to Excel — free account
MEDIROM Healthcare Technologies Inc. Unsponsored ADR
MRM Consumer Cyclical Personal Services
MEDIROM Healthcare Technologies Inc. Unsponsored ADR’s revenue for fiscal 2024 (year ended December 2024) was $54.8 million, up 13.0% from fiscal 2023.
0.36
0.02
−5.26%
Follow MRM
| Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | |
|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
6 | 2 | 6 | — | — | — | — | — |
P/S ratio |
0.05 | 0.29 | 0.23 | 0.30 | 0.00 | 0.00 | 0.00 | — |
Altman Z-Score |
0.91 | 0.86 | 0.57 | (0.04) | 0.33 | — | — | — |
Altman Z″-Score (non-manufacturers) |
(0.97) | (2.04) | (2.39) | (4.18) | (2.40) | — | (2.27) | — |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Beneish M-Score |
(1.22) | (1.97) | (1.71) | (2.66) | — | — | — | — |
P/Operating CF |
(1.20) | (6.67) | (5.40) | (7.03) | (16.73) | (17.55) | (17.55) | — |
P/B ratio |
0.64 | 15.05 | 0.00 | 0.00 | 12.54 | 41.74 | 41.74 | — |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | 25.36 | 0.00 | 0.00 | — |
EV/Sales |
0.18 | 0.53 | 0.41 | 0.49 | 0.00 | 0.00 | 0.00 | — |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
EV/Operating CF |
(0.11) | (2.60) | (2.09) | (2.59) | 0.00 | 0.00 | 0.00 | — |
EV/FCF |
(0.11) | (2.28) | (1.83) | (2.59) | 0.00 | 0.00 | 0.00 | — |
Quick Ratio |
0.56 | 0.38 | 0.54 | 0.39 | 0.77 | 0.58 | 0.37 | — |
Current Ratio |
0.65 | 0.49 | 0.65 | 0.43 | 0.79 | 0.61 | 0.40 | — |
Net Debt/EBITDA |
5.67 | (19.81) | 6.51 | (4.76) | (0.63) | 14.52 | 16.56 | — |
Debt/Assets |
23.20% | 42.13% | 36.48% | 35.42% | 33.32% | 0.00% | 63.00% | 0.00% |
Debt/Equity |
1.90 | 13.36 | (41.46) | (9.78) | 3.87 | 3.94 | (24.23) | — |
Asset Turnover |
1.07 | 0.96 | 1.03 | 0.93 | 0.66 | 1.74 | 1.51 | — |
Operating CF/Net income |
(8.95) | (5.47) | (4.60) | 0.56 | 0.68 | 0.45 | 2.14 | — |
Capex/Depreciation |
(1.95) | (3.65) | (0.44) | (0.76) | (1.13) | 0.00 | 0.00 | — |
Interest Coverage |
(0.36) | (10.62) | 9.89 | (39.40) | (56.38) | 117.67 | 14.02 | — |
| 24.38% | 152.29% | (97.49%) | (662.46%) | (99.97%) | 7.15% | 26.98% | — | |
| 1.92% | 1.63% | 2.20% | (17.00%) | (10.68%) | 0.77% | 2.91% | — | |
ROIC |
(0.45%) | (8.24%) | 3.42% | (20.54%) | (50.54%) | 0.00% | 0.00% | — |
Return on Tangible Assets |
(14.31%) | (8.55%) | (17.43%) | 71.32% | 163.66% | 1.55% | 7.69% | — |
Average Days of Receivables |
88.04 | 65.64 | 69.52 | 57.71 | 61.15 | 71.70 | 67.02 | — |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — |
Selling, General and Administrative Expense of Revenue |
27.01% | 28.71% | 25.96% | 33.69% | 31.98% | 22.31% | 24.55% | — |
Intangible Assets out of Total Assets |
0.19 | 0.21 | 0.14 | 0.17 | 0.04 | 0.00 | 0.03 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 3.64% | 0.00% | 0.00% | 0.00% | — |
Graham Net Nets |
(7.00) | (1.50) | (1.83) | (1.71) | (0.51) | (0.49) | (0.49) | — |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Free Cash Flow Yield |
(3,153.69%) | (81.10%) | (95.69%) | (62.24%) | 0.00% | 0.00% | 0.00% | — |
Revenue per Share |
10.72 | 9.93 | 10.98 | 10.09 | 7.80 | 8.91 | 7.73 | — |
Operating CF per Share |
(1.72) | (0.92) | (1.08) | (1.04) | (0.86) | 0.02 | 0.32 | — |
Capex per Share |
(0.73) | (1.34) | (0.13) | (0.18) | (0.16) | 0.00 | 0.00 | — |
Free Cash Flow per Share |
(2.45) | (2.26) | (1.21) | (1.22) | (1.02) | 0.02 | 0.32 | — |
Cash per Share |
0.43 | 0.19 | 1.00 | 0.74 | 3.44 | 1.26 | 0.55 | — |
Shareholders Equity per Share |
1.28 | 0.31 | (0.09) | (0.39) | 1.15 | 1.37 | (0.27) | — |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Book value per Share |
1.28 | 0.31 | (0.09) | (0.39) | 1.15 | 1.37 | (0.27) | — |
Free Cash Flow |
(12.52) | (11.03) | (5.90) | (5.94) | (4.11) | 0.07 | 1.28 | — |
Working Capital |
(9.74) | (12.79) | (9.85) | (16.51) | (5.31) | (8.13) | (12.91) | — |
Capital Expenditures |
(3.73) | (6.55) | (0.62) | (0.87) | (0.66) | (0.18) | (0.45) | — |
Net Current Asset Value |
(29.02) | (34.61) | (34.22) | (41.67) | (29.47) | (25.57) | (33.77) | — |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Capex to Sales |
0.07 | 0.14 | 0.01 | 0.02 | 0.02 | 0.00 | 0.00 | — |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Other line items | ||||||||
Depreciation/Fixed assets |
0.67 | 0.56 | 0.43 | 0.30 | 0.26 | 0.02 | 0.02 | — |
Cash ROIC |
(59.26%) | (48.03%) | (25.24%) | (29.32%) | (11.29%) | 0.22% | 4.74% | — |
Accounts Receivable Turnover |
5.00 | 5.13 | 5.96 | 7.55 | 5.11 | 5.62 | 4.88 | — |
Accounts Payable Turnover |
10.42 | 28.99 | 21.03 | 26.62 | 31.15 | 22.46 | 18.56 | — |
Inventory Turnover |
40.05 | 39.88 | 74.17 | 296.73 | 436.32 | 497.35 | 411.02 | — |
Average Days of Payables |
61.16 | 9.56 | 15.00 | 21.10 | 8.40 | 15.18 | 20.97 | — |
Days of Inventory on Hand |
9.14 | 9.72 | 8.24 | 1.71 | 1.00 | 0.68 | 0.95 | — |
Average Receivables |
10.96 | 9.46 | 8.99 | 6.52 | 6.15 | 6.37 | 6.37 | — |
Average Payables |
3.84 | 1.29 | 1.85 | 1.37 | 0.88 | 1.21 | 1.21 | — |
Average Inventory |
1.00 | 0.94 | 0.52 | 0.12 | 0.06 | 0.05 | 0.05 | — |
Average Assets |
51.01 | 50.29 | 52.15 | 53.03 | 47.46 | 20.61 | 20.61 | — |
Average Common Equity |
4.03 | 0.54 | (1.18) | 1.36 | 5.07 | 2.23 | 2.23 | — |
Columns are period end dates